Figure 14.
CBD improved chemotherapeutic drug effects in TRPV2-transfected Ishikawa cell line. Cell viability was determined in EC cell lines by MTT assay. Cells were treated for 72 h with CBD, alone and in combination with different doses of CIS, DOX and PAC. Data shown are expressed as mean ± SD of three separate experiments. * p < 0.05 TRPV2+ vs. control, # p < 0.05 vs. CBD alone, ç p < 0.05 vs. chemotherapeutic drug alone.